3189 results for «803»

Filter By

3189 results

PCR London Valves 2017 Opening Ceremony - Welcome address

25 Sep 2017 – From PCR London Valves 2017

PCR London Valves 2017

Welcome to Imaging Day

24 Sep 2017 – From PCR London Valves 2017

Welcome and introduction to PCR Innovators Day London

24 Sep 2017 – From PCR Innovators Day 2017

GulfPCR-GIM 2017 Opening Ceremony

13 Dec 2017 – From GulfPCR-GIM 2017

Consult the Opening ceremony of GulfPCR-GIM 2017 by W. Wijns if you want to find out more about the components of the SYNTAX II strategy and the best of PCI practice. Prevention and management of diabetes plays an important role in improving patient care in the...

GulfPCR-GIM 2017 Opening Ceremony

GulfPCR-GIM 2017 Award and Closing Ceremony

14 Dec 2017 – From GulfPCR-GIM 2017

Consult the Award and closing ceremony for GulfPCR-GIM 2017, if you find out who this year's Best Clinical Case winner is.

GulfPCR-GIM 2017: Award and Closing Ceremony

AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards

27 Jan 2018 – From AsiaPCR/SingLIVE 2018

Join U. Kaul, T.H. Koh and S.T. Lim for the AsiaPCR/SingLIVE 2018 Closing Ceremony if you want to find out who this year's Best Abstract and Best Clinical case award winners are?

AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author

Ali Nazmi Calik
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions

03 Sep 2024

Alex Sticchi provides his take on the OCCUPI trial presented by Kim Byeong-Keuk at the ESC Congress 2024 in London.

Alessandro Sticchi

Author

Alessandro Sticchi
OCCUPI - OCT-guided coronary intervention in patients with complex lesions
Didn’t find what you were looking for?